BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 35961028)

  • 1. Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features.
    Sherman MA; Graf R; Sabbagh SE; Galindo-Feria AS; Pinal-Fernandez I; Pak K; Kishi T; Flegel WA; Targoff IN; Miller FW; Lundberg IE; Rider LG; Mammen AL;
    Rheumatology (Oxford); 2023 Feb; 62(SI2):SI226-SI234. PubMed ID: 35961028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies Recognizing Specificity Protein 4 Co-occur With Anti-Transcription Intermediary Factor 1 and Are Associated With Distinct Clinical Features and Immunogenetic Risk Factors in Juvenile Myositis.
    Sherman MA; Pak K; Pinal-Fernandez I; Flegel WA; Targoff IN; Miller FW; Rider LG; Mammen AL;
    Arthritis Rheumatol; 2023 Sep; 75(9):1668-1677. PubMed ID: 36996276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-FHL1 autoantibodies in adult patients with myositis: a longitudinal follow-up analysis.
    Galindo-Feria AS; Lodin K; Horuluoglu B; Sarrafzadeh-Zargar S; Wigren E; Gräslund S; Danielsson O; Wahren-Herlenius M; Dastmalchi M; Lundberg IE;
    Rheumatology (Oxford); 2024 Jun; ():. PubMed ID: 38833674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory Myopathies.
    Ghirardello A; Gatto M; Franco C; Zanatta E; Padoan R; Ienna L; Gallo N; Zen M; Lundberg IE; Mahler M; Doria A; Iaccarino L
    Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protein tyrosine phosphatase N22 gene is associated with juvenile and adult idiopathic inflammatory myopathy independent of the HLA 8.1 haplotype in British Caucasian patients.
    Chinoy H; Platt H; Lamb JA; Betteridge Z; Gunawardena H; Fertig N; Varsani H; Davidson J; Oddis CV; McHugh NJ; Wedderburn LR; Ollier WE; Cooper RG;
    Arthritis Rheum; 2008 Oct; 58(10):3247-54. PubMed ID: 18821667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myositis-Associated Autoantibodies in Patients With Juvenile Myositis Are Associated With Refractory Disease and Mortality.
    Sherman MA; Noroozi Farhadi P; Pak K; Trieu EP; Sarkar K; Targoff IN; Neely ML; Mammen AL; Rider LG;
    Arthritis Rheumatol; 2024 Jun; 76(6):963-972. PubMed ID: 38272842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The differential role of SSa/SSb and Ro52 antibodies in defining clinical phenotypes in idiopathic inflammatory myopathies.
    Valle A; Narain S; Barilla-Labarca ML; Marder G
    Semin Arthritis Rheum; 2024 Apr; 65():152407. PubMed ID: 38377624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seasonal birth patterns in myositis subgroups suggest an etiologic role of early environmental exposures.
    Vegosen LJ; Weinberg CR; O'Hanlon TP; Targoff IN; Miller FW; Rider LG
    Arthritis Rheum; 2007 Aug; 56(8):2719-28. PubMed ID: 17665425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Features and Immunogenetic Risk Factors Associated With Additional Autoantibodies in Anti-Transcriptional Intermediary Factor 1γ Juvenile-Onset Dermatomyositis.
    Sherman MA; Yang Q; Gutierrez-Alamillo L; Pak K; Flegel WA; Mammen AL; Rider LG; Casciola-Rosen LA;
    Arthritis Rheumatol; 2024 Apr; 76(4):631-637. PubMed ID: 38059274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort.
    Tansley SL; Simou S; Shaddick G; Betteridge ZE; Almeida B; Gunawardena H; Thomson W; Beresford MW; Midgley A; Muntoni F; Wedderburn LR; McHugh NJ
    J Autoimmun; 2017 Nov; 84():55-64. PubMed ID: 28663002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic Inflammatory Myopathies.
    Balan S; Madan S
    Indian J Pediatr; 2023 Nov; ():. PubMed ID: 37919486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of anti-HSC70 autoantibodies with cutaneous ulceration and severe disease in juvenile dermatomyositis.
    Karasawa R; Yudoh K; Sato T; Tanaka M; Tamaki M; Sabbagh SE; O'Hanlon TP; Noroozi-Farhadi P; Targoff IN; Flegel WA; Mammen AL; Miller FW; Hicar MD; Rider LG; Jarvis JN
    Rheumatology (Oxford); 2022 Jul; 61(7):2969-2977. PubMed ID: 34791087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocarditis in Patients With Idiopathic Inflammatory Myopathies: Clinical Presentation and Outcomes.
    Chung MP; Lovell J; Kelly W; Mecoli CA; Albayda J; Christopher-Stine L; Gilotra NA; Paik JJ
    J Rheumatol; 2023 Aug; 50(8):1039-1046. PubMed ID: 37003604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From data to diagnosis: how machine learning is revolutionizing biomarker discovery in idiopathic inflammatory myopathies.
    McLeish E; Slater N; Mastaglia FL; Needham M; Coudert JD
    Brief Bioinform; 2023 Nov; 25(1):. PubMed ID: 38243695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the sensitivity and specificity of myositis-specific and associated autoantibodies: a sub-study from the MyoCite cohort.
    Loganathan A; Gupta L; Rudge A; Lu H; Bowler E; McMorrow F; Naveen R; Anuja AK; Agarwal V; McHugh N; Tansley S
    Rheumatology (Oxford); 2024 Mar; ():. PubMed ID: 38479813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of anti-TPM4 autoantibodies with vasculopathic cutaneous manifestations in juvenile dermatomyositis.
    Karasawa R; Yudoh K; Sato T; Tanaka M; Sabbagh SE; Flegel WA; Mammen AL; Jarvis JN; Rider LG;
    Rheumatology (Oxford); 2023 Nov; 62(11):3757-3762. PubMed ID: 37144941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subsets of Idiopathic Inflammatory Myositis Enriched for Contemporaneous Cancer Relative to the General Population.
    Mecoli CA; Igusa T; Chen M; Wang X; Albayda J; Paik JJ; Tiniakou E; Adler B; Richardson C; Kelly W; Danoff S; Mammen AL; Platz EA; Rosen A; Christopher-Stine L; Casciola-Rosen L; Shah AA
    Arthritis Rheumatol; 2023 Apr; 75(4):620-629. PubMed ID: 35878018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between self-reported race and ethnicity and myositis-specific autoantibodies in a diverse cohort of patients with inflammatory myopathy.
    Beam MJ; Montgomery A; Anastasiou C; Schmajuk G
    Clin Rheumatol; 2023 Nov; 42(11):3043-3047. PubMed ID: 37542130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The EuroMyositis registry: an international collaborative tool to facilitate myositis research.
    Lilleker JB; Vencovsky J; Wang G; Wedderburn LR; Diederichsen LP; Schmidt J; Oakley P; Benveniste O; Danieli MG; Danko K; Thuy NTP; Vazquez-Del Mercado M; Andersson H; De Paepe B; deBleecker JL; Maurer B; McCann LJ; Pipitone N; McHugh N; Betteridge ZE; New P; Cooper RG; Ollier WE; Lamb JA; Krogh NS; Lundberg IE; Chinoy H;
    Ann Rheum Dis; 2018 Jan; 77(1):30-39. PubMed ID: 28855174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and laboratory characteristics of idiopathic inflammatory myositis in Saudi patients: A retrospective study in a single tertiary centre.
    Alenzi F; Alotaibi J; Alnasser M; Alokaily F
    Saudi Med J; 2023 May; 44(5):492-497. PubMed ID: 37182927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.